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Aims: The examination of human skeletal remains from archaeo- 
logical excavations is a novel means of studying OA The ability to 
directly observe all joints of the body provides a perspective of 
the disease unobtainable from clinical studies. Evidence of OA in 
the form of osteophytes and eburnation (indicative of articular 
cartilage loss), is readily observable where present. The aim of 
this study was to investigate associations of OA between differ- 
ent joints and assess the evidence for generalized OA (GOA). 
Methods: 563 skeletons excavated from a single site in the UK 
were studied. The time of burial ranged from 900AD to 1850AD. 
The articular surfaces of the hips, knees (both the TFJ and PFJ 
sites), hands (IPJs, MCPJs and 1st CMCJ) and elbows were 
examined for the presence of osteophytes and eburnation by an 
experienced palaeopathologist. Standard anthropomorphic tech- 
niques were used to estimate age at death ( <45 years or >45 
years) and sex. 
Results: Of the 563 individuals in the study sample, 48% were 
female and 37% were estimated >45 years age at death. The 
prevalence of osteophytes was 15.4%, 11.0%, 16.5% and 23.8% 
in the hip, knee, elbow and hand respectively; for ebumation the 
prevalences were 2.3%, 3.9%, 4.2% and 9.4% respectively. The 
associations between joints are shown below, quantified as 
ManteI-Haenzsel odds ratios, adjusted for age and sex, with 95% 
confidence intervals. 
Osteophytes Hip Knee Hand 
Knee 8.4 (4.3. 16.4) 
Hand 3.2 (1.8. 5.6 ) 3.3 (1.6, 6.8 ) - 
Elbow 7.1 (4.0, 12.7) 10.0 (5.4, 18.5) 3.9 (2.2, 7.2) 
Eburnation Hip Knee Hand 
Knee * 
Hand 2.9(0.8,11.1) 5.2 (1.8, 15.4) 
Elbow * 16.4 (4.6, 58.7) 3.2 (1.2.8.8) 
*(Unable to calculate due to zero cell frequencies) 
Conclusions: These data indicate that OA is by no means a mod- 
ern disease. Further, considering only bony pathology, moderate 
to strong associations were clearly apparent between joints. This 
included strong relationships with the elbow, a joint hitherto not 
considered in the classic GOA definition. This suggests GOA be 
re-conceptualized as a linkage of pathologically affected joints 
and not necessarily symptomatic joints. 
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Articular cartilage is considered to contain only mature chondro- 
cytes with distinct functional properties in the various zones of 
this tissue. Here we report for the first time the presence of mes- 
enchymal progenitor cells in human articular cartilage. Primary 
cell cultures established from normal human articular cartilage 
(donors aged 17-39; n14) were analyzed for the expression of CD 
105 and CD 166, cell surface markers, whose co-expression 
defines bone marrow-derived mesenchymal stem cells (BM- 
MSC). Up to 95% of isolated cartilage cells were CD105+ and 
approximately 5% were CD166+. The percentage of 
CD105+/CD166+ (double positive) cells was 3.49 ± 1.93%. 
Primary cell cultures from osteoarthritic (OA) cartilage contained 
$7 
significantly increased numbers of CD105+/CD166+ cells in the 
OA lesions (7.47 ± 3.8%, n:=14) as well as in the normal appear- 
ing cartilage from OA joints (7.88 ± 6.0%). Confocal microscopy 
confirmed the co-expression of both markers in the majority of 
BM- MSC and a subpopulation of cartilage cells. The potential of 
cells isolated from articular cartilage to differentiate to adipogenic 
and chondrogenic lineages was analyzed after immunomagnetic 
selection for CD 105+/CD166+ cells and was compared to BM- 
MSC. Differentiation to adipocytes occurred in cartilage-derived 
cell cultures as indicated by characteristic ell morphology and 
oil Red O staining of lipid vacuoles. Purified cartilage-derived CD 
t05+ /CD 166+ cells did not express markers of differentiated 
chondrocytes. However, the cells were capable of chondrocytic 
differentiation and formed cartilage tissue in micromass pellet 
cultures. These findings indicate hat multipotential mesenchymal 
progenitor cells are present in articular cartilage from adult 
humans and that their frequency is increased in OA cartilage. This 
observation has implications for understanding the intrinsic repair 
capacity of articular cartilage and raises the possibility that these 
progenitor cells might be involved in the pathogenesis of arthritis. 
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Bisphosphonates induce a significant reduction in bone resorp- 
tion, which is apparent as a pronounced ecrease in biochemical 
markers of bone resorption and, over time, as an increase in bone 
mineral density. We wanted to assess the effect of bisphospho- 
nates on cartilage destruction. We therefore quantified cartilage 
degradation in bisphosphonate treated individuals by measure- 
ment of degradation fragments of Collagen type II by a newly 
developed immunoassay. 
Methods and Results: Decrease in cartilage degradation 
induced by steroid treatment in RA. CartiLaps levels were meas- 
ured in urine samples from postmenopausal women participating 
in two dose finding studies of bisphosphonates. The first study 
cohort comprised 63 women 40-59 years of age (52.5 years in 
mean) treated with either placebo, or 1,5, 10 or 20 mg daily. The 
second study cohort comprised 145 women that were at least 10 
years postmenopausal and below 75 years of age (65 years in 
mean) treated with either placebo, or 0.25, 0.5, 1, 2.5 or 5 mg 
daily. Within 3 months mean u-CartiLaps significantly decreased 
approximately 50% for the highest doses of both bisphospho- 
nates. Bone formation measured by s-NMid Osteocalcin 
decreased with 76% in both studies. In the two studies bone 
resorption measured by s-CrossLaps decreased to 60.43% and 
35.1% of baseline values respectively. Mean u-CartiLaps 
decreased in a dose dependent manner for both bisphospho- 
nates. The decrease in mean u-CartiLaps became significant 
from baseline value within 3 months of treatment for daily doses 
>/t= 5 mg and 0.5 mg treatment was stopped, CartiLaps values 
returned to baseline values in both study cohorts. 
Conclusions: Our studies indicate that bisphosphonates are able 
to reduce cartilage degradation in healthy postmenopausal 
women. Further studies lasting longer than ours and involving 
larger cohorts including patients with OA are needed to fully 
address the potential chondroprotective effects of bisphospho- 
hates. 
